Cyber Sport's Orbita Mouse doesn't want to be just another regular, boring mouse -- and its newness goes way beyond looks. We don't review too many mice around these parts, but this one seemed to call ...

Disease pattern is a strong modifier of how much PCI will reduce angina and may explain prior negative trials in this space.

For a study with a mere 200 patients and relatively short follow-up, the ORBITA trial has punched well beyond its weight, sparking debate among interventional and general cardiologists alike about the ...

It may look like Apple's ill-fated puck mouse, but the Cyber Sport Orbita Mouse is a whole lot cleverer under its silicone skin. Free-rotating for super convenient scrolling, the Orbita can be as ...

Editor’s note: This post is part of a Health Affairs Blog series titled “ORBITA: Lessons From A Landmark Trial," which focuses on the recent study finding that coronary stenting did not improve ...

We've seen the Cyber Sport Orbita Mouse bouncing around the Internets for about a year in search of a manufacturer. Now they've got it, with a corresponding January 2009 retail delivery date to match.

Orbita, a voice and AI health IT technology company, has unveiled a major upgrade to its Orbita Voice platform that enables healthcare provider organizations to create and maintain applications for ...

Rasha Al-Lamee, MD (Imperial College London, United Kingdom) calmly delivered the findings that improvements in exercise capacity and angina symptoms were not significantly different between patients ...

PARIS — New findings from the controversial ORBITA trial provide a lift for percutaneous coronary intervention (PCI) in stable angina but also mixed results for the predictive power of fractional flow ...

Editor’s note: This post is part of a Health Affairs Blog series titled “ORBITA: Lessons From A Landmark Trial," which focuses on the recent study finding that coronary stenting did not improve ...